Cochlear Limited (ASX:COH – Get Free Report) insider Karen Penrose purchased 100 shares of the business’s stock in a transaction dated Wednesday, February 18th. The shares were purchased at an average cost of A$201.22 per share, with a total value of A$20,122.00.
Cochlear Price Performance
The company has a market cap of $19.88 billion, a P/E ratio of 55.90, a P/E/G ratio of 3.87 and a beta of 0.47. The company has a debt-to-equity ratio of 13.24, a current ratio of 2.30 and a quick ratio of 1.93.
Cochlear Announces Dividend
The firm also recently announced a Interim dividend, which will be paid on Sunday, April 12th. Shareholders of record on Sunday, April 12th will be given a $2.15 dividend. This represents a yield of 107.0%. The ex-dividend date of this dividend is Wednesday, March 18th. Cochlear’s payout ratio is currently 77.35%.
Cochlear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
Further Reading
- Five stocks we like better than Cochlear
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- From Quiet Compounder to 2026 Breakout? BSEM
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with MarketBeat.com's FREE daily email newsletter.
